JG
Congress trade
Rep. Josh Gottheimer (D-NJ) sold $1K-$15K of Regeneron Pharmaceuticals, Inc. (REGN) stock
Josh Gottheimer, U.S. Representative (D-NJ), disclosed a sale of Regeneron Pharmaceuticals, Inc. (REGN) stock worth $1K-$15K in a STOCK Act filing on Dec 5, 2024.
The trade happened on Nov 29, 2024, 6 days before it was made public.
REGN has moved -2.0% since the trade date, from $750.22 to $735.20 (Oct 2, 2026 close).
- Traded
- Nov 29, 2024
- Disclosed
- Dec 5, 2024
- Filing delay
- 6 days
- Price since
- -2.0%
- Source
- STOCK Act disclosure
Other trades in this disclosure (36)
- BuyMSFT$1M-$5MDec 5, 2024
- BuyMSFT$1M-$5MDec 5, 2024
- BuyMSFT$1M-$5MDec 5, 2024
- SellMSFT$1M-$5MDec 5, 2024
- SellMSFT$1M-$5MDec 5, 2024
- SellMSFT$1M-$5MDec 5, 2024
- BuyAPP$1K-$15KDec 5, 2024
- SellCOP$1K-$15KDec 5, 2024
- BuyCRM$1K-$15KDec 5, 2024
- BuyCRM$1K-$15KDec 5, 2024
- BuyCRM$1K-$15KDec 5, 2024
- BuyD$1K-$15KDec 5, 2024
- BuyDHI$1K-$15KDec 5, 2024
- SellETN$1K-$15KDec 5, 2024
- SellFOXF$1K-$15KDec 5, 2024
- SellHQY$1K-$15KDec 5, 2024
- BuyJNJ$1K-$15KDec 5, 2024
- BuyJNJ$1K-$15KDec 5, 2024
- BuyKKR$1K-$15KDec 5, 2024
- SellLLY$1K-$15KDec 5, 2024
More REGN insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.